Mark Liebow

3.7k citations

44 papers · 1.5k indexed · h-index 23

Impact in

Health Information Management top 5%
Pathology and Forensic Medicine top 5%
- Lymphoma Diagnosis and Treatment

Papers in ⓘ

Pathology and Forensic Medicine 12
- Lymphoma Diagnosis and Treatment 10
Family Practice 1

Co-authors: Zachary S. Fredericksen (18 shared papers)James R. Cerhan (21 shared papers)Susan L. Slager (20 shared papers)Alice H. Wang (14 shared papers)Timothy G. Call (15 shared papers)Thomas M. Habermann (17 shared papers)Julie M. Cunningham (12 shared papers)Stephen M. Ansell (12 shared papers)
Journals: Mayo Clinic Proceedings (5 papers)Cancer Epidemiology Biomarkers & Prevention (5 papers)Journal of General Internal Medicine (4 papers)British Journal of Haematology (3 papers)International Journal of Cancer (3 papers)
Partner nations: United States Belarus Vietnam

In The Last Decade

Mark Liebow

44 papers receiving 1.5k citations

Peers

Countries citing papers authored by Mark Liebow

Since Specialization

Citations

This map shows the geographic impact of Mark Liebow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Liebow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Liebow more than expected).

Fields of papers citing papers by Mark Liebow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Liebow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Liebow. The network helps show where Mark Liebow may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Liebow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Liebow Line = papers co-authored together Mark Liebow links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Views of US Physicians About Controlling Health Care Costs JAMA ·Jon C. Tilburt, Matthew K. Wynia, Robert D. Sheeler, Björg Thorsteinsdottir, Katherine M. James, Jason S. Egginton, Mark Liebow, Samia Hurst, Marion Danis, Susan Dorr Goold	2013	186
2	The Mayo Clinic Biobank: A Building Block for Individualized Medicine Mayo Clinic Proceedings ·Janet E. Olson, Euijung Ryu, Kiley J. Johnson, Barbara A. Koenig, Karen J. Maschke, Jody A. Morrisette, Mark Liebow, Paul Y. Takahashi, Zachary S. Fredericksen, Ruchi Sharma, Kari Anderson, Matthew Hathcock, Jason A. Carnahan, Jyotishman Pathak, Noralane M. Lindor, Timothy J. Beebe, Stephen N. Thibodeau, James R. Cerhan	2013	151
3	Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma Blood ·James R. Cerhan, Stephen M. Ansell, Zachary S. Fredericksen, Neil E. Kay, Mark Liebow, Timothy G. Call, Ahmet Doǧan, Julie M. Cunningham, Alice H. Wang, Wen Liu‐Mares, William R. Macon, Diane F. Jelinek, Thomas E. Witzig, Thomas M. Habermann, Susan L. Slager	2007	119
4	Why the C-statistic is not informative to evaluate early warning scores and what metrics to use Critical Care ·Santiago Romero‐Brufau, Jeanne M. Huddleston, Gabriel J. Escobar, Mark Liebow	2015	98
5	Medicare financing of graduate medical education Journal of General Internal Medicine ·Eugene C. Rich, Mark Liebow, Malathi Srinivasan, David C. Parish, James O. Wolliscroft, Oliver Fein, Robert Blaser	2002	75
6	Cost-Minimization Analysis of Alternative Diagnostic Approaches in a Modeled Patient With Non-Small Cell Lung Cancer and Subcarinal Lymphadenopathy Mayo Clinic Proceedings ·Gavin C. Harewood, Maurits J. Wiersema, Eric S. Edell, Mark Liebow	2002	63
7	Genetic Variation in Tumor Necrosis Factor and the Nuclear Factor-κB Canonical Pathway and Risk of Non-Hodgkin's Lymphoma Cancer Epidemiology Biomarkers & Prevention ·James R. Cerhan, Wen Liu‐Mares, Zachary S. Fredericksen, Anne J. Novak, Julie M. Cunningham, Neil E. Kay, Ahmet Doǧan, Mark Liebow, Alice H. Wang, Timothy G. Call, Thomas M. Habermann, Stephen M. Ansell, Susan L. Slager	2008	57
8	Genetic Variation in B-Cell–Activating Factor Is Associated with an Increased Risk of Developing B-Cell Non–Hodgkin Lymphoma Cancer Research ·Anne J. Novak, Susan L. Slager, Zachary S. Fredericksen, Alice H. Wang, Michelle M. Manske, Steven C. Ziesmer, Mark Liebow, William R. Macon, Stacey R. Dillon, Thomas E. Witzig, James R. Cerhan, Stephen M. Ansell	2009	54
9	Genetic Variation in the One-Carbon Transfer Pathway and Ovarian Cancer Risk Cancer Research ·Linda E. Kelemen, Thomas A. Sellers, Joellen M. Schildkraut, Julie M. Cunningham, Robert A. Vierkant, V. Shane Pankratz, Zachary S. Fredericksen, Madhura K. Gadre, David N. Rider, Mark Liebow, Ellen L. Goode	2008	50
10	The introduction of a diagnostic decision support system (DXplain™) into the workflow of a teaching hospital service can decrease the cost of service for diagnostically challenging Diagnostic Related Groups (DRGs) International Journal of Medical Informatics ·Peter L. Elkin, Mark Liebow, Brent A. Bauer, Swarna Chaliki, Dietlind L. Wahner‐Roedler, John B. Bundrick, Mark Lee, Steven H. Brown, David A. Froehling, Kent R. Bailey, Kathleen T. Famiglietti, Richard Kim, Edward P. Hoffer, Mitchell D. Feldman, G. Octo Barnett	2010	47
11	Estrogen Bioactivation, Genetic Polymorphisms, and Ovarian Cancer Cancer Epidemiology Biomarkers & Prevention ·Thomas A. Sellers, Joellen M. Schildkraut, V. Shane Pankratz, Robert A. Vierkant, Zachary S. Fredericksen, Janet E. Olson, Julie M. Cunningham, William Taylor, Mark Liebow, Carol McPherson, Lynn C. Hartmann, Tuya Pal, Araba A. Adjei	2005	47
12	Cost-Minimization Analysis of Alternative Diagnostic Approaches in a Modeled Patient With Non-Small Cell Lung Cancer and Subcarinal Lymphadenopathy Mayo Clinic Proceedings ·Gavin C. Harewood, Maurits J. Wiersema, Eric S. Edell, Mark Liebow	2002	44
13	Association of Single Nucleotide Polymorphisms in Glycosylation Genes with Risk of Epithelial Ovarian Cancer Cancer Epidemiology Biomarkers & Prevention ·Thomas A. Sellers, Yifan Huang, Julie M. Cunningham, Ellen L. Goode, Rebecca Sutphen, Robert A. Vierkant, Linda E. Kelemen, Zachary S. Fredericksen, Mark Liebow, V. Shane Pankratz, Lynn C. Hartmann, Jeff Myer, Edwin S. Iversen, Joellen M. Schildkraut, Catherine Phelan	2008	37
14	Food‐frequency questionnaire‐based estimates of total antioxidant capacity and risk of non‐Hodgkin lymphoma International Journal of Cancer ·Shernan G. Holtan, Helen M. O’Connor, Zachary S. Fredericksen, Mark Liebow, Carrie A. Thompson, William R. Macon, Ivana N. Micallef, Alice H. Wang, Susan L. Slager, Thomas M. Habermann, Timothy G. Call, James R. Cerhan	2011	36
15	Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma Cancer Causes & Control ·Jennifer L. Kelly, Matthew T. Drake, Zachary S. Fredericksen, Yan W. Asmann, Mark Liebow, Tait D. Shanafelt, Andrew L. Feldman, Stephen M. Ansell, William R. Macon, Megan M. Herr, Alice H. Wang, Grzegorz S. Nowakowski, Timothy G. Call, Thomas M. Habermann, Susan L. Slager, Thomas E. Witzig, James R. Cerhan	2012	35
16	Germline Variation in Apoptosis Pathway Genes and Risk of Non–Hodgkin's Lymphoma Cancer Epidemiology Biomarkers & Prevention ·Jennifer L. Kelly, Anne J. Novak, Zachary S. Fredericksen, Mark Liebow, Stephen M. Ansell, Ahmet Doǧan, Alice H. Wang, Thomas E. Witzig, Timothy G. Call, Neil E. Kay, Thomas M. Habermann, Susan L. Slager, James R. Cerhan	2010	34
17	trans Fatty Acid Intake Is Associated with Increased Risk and n3 Fatty Acid Intake with Reduced Risk of Non-Hodgkin Lymphoma Journal of Nutrition ·Bridget Charbonneau, Helen M. O’Connor, Alice H. Wang, Mark Liebow, Carrie A. Thompson, Zachary S. Fredericksen, William R. Macon, Susan L. Slager, Timothy G. Call, Thomas M. Habermann, James R. Cerhan	2013	32
18	Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. PubMed ·James R. Cerhan, Zachary S. Fredericksen, Alice H. Wang, Thomas M. Habermann, Neil E. Kay, William R. Macon, Julie M. Cunningham, Tait D. Shanafelt, Stephen M. Ansell, Timothy G. Call, Thomas E. Witzig, Susan L. Slager, Mark Liebow	2011	31
19	Perioperative Evaluation and Management of Endocrine Disorders Mayo Clinic Proceedings ·Carina P. Himes, Ravindra Ganesh, Elizabeth C. Wight, Vinaya Simha, Mark Liebow	2020	26
20	History of autoimmune conditions and lymphoma prognosis Blood Cancer Journal ·Geffen Kleinstern, Matthew J. Maurer, Mark Liebow, Thomas M. Habermann, Jean L. Koff, Cristine Allmer, Thomas E. Witzig, Grzegorz S. Nowakowski, Ivana N. Micallef, Patrick B. Johnston, David J. Inwards, Carrie A. Thompson, Andrew L. Feldman, Brian K. Link, Christopher R. Flowers, Susan L. Slager, James R. Cerhan	2018	24

About Mark Liebow

Mark Liebow is a scholar working on Pathology and Forensic Medicine, Family Practice, Cancer Research, Genetics and Reproductive Medicine, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Healthcare cost, quality, practices (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Healthcare Policy and Management (4 papers), Viral-associated cancers and disorders (3 papers), Innovations in Medical Education (3 papers), NF-κB Signaling Pathways (3 papers) and Primary Care and Health Outcomes (3 papers). The work is most often cited by research in Health Information Management (58 citations), Pathology and Forensic Medicine (225 citations), Family Practice (25 citations), Health Informatics (14 citations) and Genetics (111 citations). Mark Liebow has collaborated with scholars based in United States, Belarus and Vietnam. Frequent co-authors include Zachary S. Fredericksen, James R. Cerhan, Susan L. Slager, Alice H. Wang, Timothy G. Call, Thomas M. Habermann, Julie M. Cunningham, Stephen M. Ansell, Gavin C. Harewood and Eric S. Edell. Their work appears in journals such as Mayo Clinic Proceedings, Cancer Epidemiology Biomarkers & Prevention, Journal of General Internal Medicine, British Journal of Haematology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact